Insider · CIK 0002001881
Juan Diaz-Cartelle
Files at MBOT (Microbot Medical Inc.). First filing -, latest -.
Juan Diaz-Cartelle files SEC Form 4 as officer at MBOT (Microbot Medical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Juan Diaz-Cartelle has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Feb 20, 2026 |
| Feb 5, 2025 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +42,000 | $0.00 | $0 | 42,000 | Feb 7, 2025 |
| Feb 26, 2024 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,500 | $0.00 | $0 | 10,500 | Feb 7, 2025 |
Questions about Juan Diaz-Cartelle
Answered from the filings on this page, as of the latest one.
Is Juan Diaz-Cartelle buying or selling?
Juan Diaz-Cartelle has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Juan Diaz-Cartelle's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Juan Diaz-Cartelle has 0.
Where does Juan Diaz-Cartelle file Form 4?
Juan Diaz-Cartelle has filed Form 4 at MBOT (Microbot Medical Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.